NDTVCenter·
Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%
Strong growth in CDMO and hospital generics businesses lifts revenue, while operating profitability improves sharply despite a quarterly loss.
Read at NDTV →
Business · 1 sources covering this
Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%
Strong growth in CDMO and hospital generics businesses lifts revenue, while operating profitability improves sharply despite a quarterly loss.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/6b55399b8413df1df5db74a10d3f5f925e90e792" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Piramal Pharma Q1 Results: Net Loss Narrows As Margin Expands; Revenue Up 17%"></iframe>
